BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2098299)

  • 1. Thrombotic complications during L-asparaginase treatment for acute lymphocytic leukemia.
    Castaman G; Rodeghiero F; Dini E
    Haematologica; 1990; 75(6):567-9. PubMed ID: 2098299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erwinia- and E. coli-derived L-asparaginase have similar effects on hemostasis. Pilot study in 10 patients with acute lymphoblastic leukemia.
    Castaman G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):57-60. PubMed ID: 8039761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cerebral thrombosis in a child with acute lymphocytic leukemia during L-asparaginase therapy].
    Horigome Y; Hanada T; Inudoh M; Takita H
    Rinsho Ketsueki; 1989 Aug; 30(8):1284-8. PubMed ID: 2601047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study.
    Bassan R; Pogliani E; Lerede T; Fabris P; Rossi G; Morandi S; Casula P; Lambertenghi-Deliliers G; Vespignani M; Izzi T; Coser P; Corneo G; Barbui T
    Haematologica; 1999 Dec; 84(12):1088-93. PubMed ID: 10586210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Superior sagittal sinus thrombosis following L-asparaginase therapy of acute lymphoblastic leukemia].
    Watanabe I; Sakai I; Matsumoto I
    Rinsho Ketsueki; 1992 Mar; 33(3):343-8. PubMed ID: 1578639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Superior sagittal sinus thrombosis during remission induction therapy for acute lymphoblastic leukemia].
    Yoshimi A; Taoka K; Nakasone H; Iijima K; Kida M; Iki S; Urabe A; Usuki K
    Rinsho Ketsueki; 2006 Dec; 47(12):1533-8. PubMed ID: 17233472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000.
    Attarbaschi A; Mann G; Kronberger M; Witt V; Gadner H; Dworzak M
    Klin Padiatr; 2003; 215(6):321-6. PubMed ID: 14677096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy: a retrospective study. The GIMEMA Group.
    Gugliotta L; Mazzucconi MG; Leone G; Mattioli-Belmonte M; Defazio D; Annino L; Tura S; Mandelli F
    Eur J Haematol; 1992 Aug; 49(2):63-6. PubMed ID: 1397242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of a hypercoagulable state in patients with acute lymphoblastic leukemia treated with low dose of E. coli L-asparaginase: a GIMEMA study.
    Leone G; Gugliotta L; Mazzucconi MG; De Stefano V; Belmonte MM; Dragoni F; Specchia G; Centra A; Gamba G; Camera A
    Thromb Haemost; 1993 Jan; 69(1):12-5. PubMed ID: 8446931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
    Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
    Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Venous thrombosis of cranial sinuses in asparaginase therapy. A case report].
    Schulz U; Mann G; Zoubek A; Gadner H
    Klin Padiatr; 1994; 206(4):342-5. PubMed ID: 7967436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A regimen for antithrombin III substitution in patients with acute lymphoblastic leukemia under treatment with L-asparaginase.
    Mattioli Belmonte M; Gugliotta L; Delvos U; Catani L; Vianelli N; Cascione ML; Belardinelli AR; Mottola L; Tura S
    Haematologica; 1991; 76(3):209-14. PubMed ID: 1743591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic effects of asparaginase in two acute lymphoblastic leukemia protocols (NOPHO ALL-1992 versus NOPHO ALL-2000): a single-institution study.
    Ruud E; Holmstrøm H; de Lange C; Natvig S; Albertsen BK; Wesenberg F
    Pediatr Hematol Oncol; 2006; 23(3):207-16. PubMed ID: 16517537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols).
    Mauz-Körholz C; Junker R; Göbel U; Nowak-Göttl U
    Thromb Haemost; 2000 Jun; 83(6):840-3. PubMed ID: 10896235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [L-asparaginase therapy against hybrid leukemia: a case report].
    Mitani K; Kobayashi Y; Kawamura Y; Usuki K; Yuo A; Ishikawa F; Kitamura T; Ozawa K; Kitamura K; Urabe A
    Rinsho Ketsueki; 1988 Sep; 29(9):1442-6. PubMed ID: 3216516
    [No Abstract]   [Full Text] [Related]  

  • 16. Roles of protein C, protein S, and antithrombin III in acute leukemia.
    Dixit A; Kannan M; Mahapatra M; Choudhry VP; Saxena R
    Am J Hematol; 2006 Mar; 81(3):171-4. PubMed ID: 16493609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive therapy for adult acute lymphoblastic leukemia: preliminary results of the idarubicin/vincristine/L-asparaginase/prednisolone regimen.
    Bassan R; Battista R; Viero P; Pogliani E; Rossi G; Lambertenghi-Deliliers G; Rambaldi A; D'Emilio A; Buelli M; Borleri G
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):39-46. PubMed ID: 7507263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
    van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
    Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases.
    Appel IM; Hop WC; Pieters R
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):139-46. PubMed ID: 16479196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of hypertriglyceridemia induced by L-asparaginase therapy for acute lymphoblastic leukemia and malignant lymphoma.
    Tozuka M; Yamauchi K; Hidaka H; Nakabayashi T; Okumura N; Katsuyama T
    Ann Clin Lab Sci; 1997; 27(5):351-7. PubMed ID: 9303174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.